Internal Medicine, Medical Oncology · Cleveland, OH
NPI
1043509862
Since 2011
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9500 Euclid Ave # CA-60
Cleveland, OH, 44195
Phone (216) 445-6592
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
899 services
Medicare patients, 2024
250
Average age 74
Drug cost, 2024
$10.2M
1,237 prescriptions
Company payments, 2025
$21K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Moshe C Ornstein was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 283 times for 157 patients. In total Moshe C Ornstein billed 899 services in 20 codes, and Medicare paid $49K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 283 | 157 | $12.35 | $3,496 |
| 99215 Office E&M - Established | Facility | 182 | 89 | $98.24 | $18K |
| 99214 Office E&M - Established | Facility | 87 | 66 | $66.90 | $5,821 |
| 99441 Telephone Services | Facility | 64 | 50 | $24.37 | $1,560 |
| 99233 Hospital E&M - Subsequent | Facility | 52 | 24 | $89.61 | $4,659 |
| 99213 Office E&M - Established | Facility | 33 | 28 | $41.16 | $1,358 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 28 | 24 | $12.49 | $350 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 14 | $59.45 | $1,546 |
| 99214 Office E&M - Established | Office | 24 | 23 | $88.06 | $2,113 |
| 99213 Office E&M - Established | Office | 22 | 18 | $63.72 | $1,402 |
| 99204 Office E&M - New | Facility | 20 | 20 | $83.12 | $1,662 |
| 99442 Telephone Services | Facility | 11 | 11 | $49.60 | $546 |
By year: 2022 $49K for 602 services; 2023 $40K for 565 services; 2024 $49K for 899 services.
Medicare prescription drug claims, 2024
In 2024, the drug Moshe C Ornstein prescribed most often to Medicare patients was Prednisone, with 164 prescriptions and refills. In total Moshe C Ornstein wrote 1,237 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 164 | 213 | 48 | $637 |
| Abiraterone Acetate Generic | 162 | 166 | 32 | $184K |
| Erleada Apalutamide | 160 | 163 | 26 | $2.3M |
| Cabometyx Cabozantinib S-Malate | 96 | 98 | 12 | $1.8M |
| Inlyta Axitinib | 93 | 93 | 16 | $2.0M |
| Xtandi Enzalutamide | 67 | 67 | Under 11 | $709K |
| Lenvima Lenvatinib Mesylate | 51 | 51 | 11 | $1.4M |
| Orgovyx Relugolix | 48 | 50 | 12 | $127K |
| Welireg Belzutifan | 43 | 43 | 11 | $972K |
| Levothyroxine Sodium Generic | 32 | 75 | 12 | $203 |
| Amlodipine Besylate Generic | 26 | 40 | Under 11 | $206 |
| Methylphenidate Hcl Generic | 25 | 25 | Under 11 | $622 |
| Bicalutamide Generic | 23 | 49 | 13 | $740 |
| Eliquis Apixaban | 16 | 26 | Under 11 | $15K |
| Lisinopril Generic | 16 | 22 | Under 11 | $91.95 |
Brand drugs: 614 claims; generic drugs: 623 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Moshe C Ornstein $21K ($21K in general payments such as food, travel and fees) from 7 companies. The largest payer was Eisai Inc. with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.